Horizon therapeutics public limited company (HZNP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net sales

1,375,567

1,300,029

1,292,027

1,281,872

1,264,060

1,207,570

1,126,246

1,072,581

1,059,253

1,056,231

1,092,362

1,029,418

997,289

981,120

915,308

933,150

848,593

757,044

616,347

464,929

358,170

296,955

223,194

172,180

117,249

74,016

49,895

32,304

25,014

18,844

16,411

10,163

7,657

6,927

0

0

0

-

-

Cost of goods sold

371,449

362,175

365,853

366,981

369,155

391,301

391,287

425,727

464,540

493,368

543,264

502,908

453,884

392,001

311,093

287,182

267,882

219,502

184,609

137,003

99,987

78,753

51,328

40,891

18,475

14,625

12,513

13,116

13,577

11,875

10,807

8,246

7,495

7,267

5,929

6,812

0

0

0

Sale of goods

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

3,979

5,403

0

0

0

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

Gross sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

18,364

11,326

8,053

6,939

4,090

5,474

0

0

0

Sales discounts and allowances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

-

-

-

-

-

-

Gross profit

1,004,118

937,854

926,174

914,891

894,905

816,269

734,959

646,854

594,713

562,863

549,098

526,510

543,405

589,119

604,215

645,968

580,711

537,542

431,738

327,926

258,183

218,202

171,866

131,289

98,774

59,391

37,382

19,188

11,437

6,969

5,604

1,917

162

-340

-1,839

-1,338

0

0

0

OPERATING EXPENSES:
Research and development

108,684

103,200

94,332

90,929

86,880

82,800

93,989

90,748

229,584

225,000

218,051

212,937

61,046

60,707

50,435

50,694

48,406

41,865

35,035

26,185

20,808

17,460

13,500

11,431

10,719

10,084

11,924

13,566

14,966

16,837

15,919

17,469

16,698

15,358

17,258

16,204

0

0

0

Selling, general and administrative

772,587

697,111

686,347

675,606

685,185

692,485

685,281

677,648

660,627

655,093

683,155

661,252

635,174

603,048

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on sale of assets

-

-

-

0

-

-

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

46,096

57,520

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sales and marketing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

190,436

169,574

138,644

120,276

107,052

91,562

80,962

68,595

63,570

60,900

54,917

49,561

47,353

39,543

30,169

20,314

9,382

5,638

0

0

0

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

179,961

163,554

104,045

88,957

74,550

42,315

29,816

23,566

21,006

19,810

19,183

19,444

18,806

18,320

17,113

15,008

14,518

16,121

0

0

0

Total operating expenses

892,203

811,243

771,768

746,924

741,491

778,358

802,179

802,005

946,090

902,325

994,736

967,719

767,480

735,015

583,225

557,924

557,307

482,170

405,432

359,313

263,497

226,693

195,102

145,308

121,497

102,245

96,500

94,276

89,066

85,842

151,699

144,953

133,601

120,301

41,158

37,963

0

0

0

Operating loss

111,915

126,611

154,406

167,967

153,414

37,911

-67,220

-155,151

-351,377

-339,462

-445,638

-441,209

-224,075

-145,896

20,990

88,044

23,404

55,372

26,306

-31,387

-5,314

-8,491

-23,236

-14,019

-22,723

-42,854

-59,118

-75,088

-77,629

-78,873

-146,095

-143,036

-133,439

-120,641

-42,997

-39,301

0

0

0

OTHER EXPENSE, NET:
Interest expense, net

-76,903

-87,089

-99,762

-109,771

-118,768

-121,692

-123,147

-124,416

-124,994

-126,523

-124,155

-111,515

-99,135

-86,610

-77,872

-79,106

-79,326

-69,900

-76,826

-61,720

-38,065

-23,826

-20,200

-11,405

-12,170

-12,774

11,117

10,855

10,604

11,552

11,900

9,556

9,550

6,284

6,496

6,024

0

0

0

Loss on debt extinguishment

-

-58,835

0

0

0

-

-

-

-

-978

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on divestiture

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Foreign exchange gain (loss)

870

33

-137

-62

-143

-192

-507

-267

-111

-260

-572

-955

-1,091

-1,005

-493

-471

-573

-1,237

-1,839

-4,507

-4,704

-3,905

-2,537

1,335

2,073

1,206

1,468

938

-917

489

-1,109

-2,455

-944

-1,023

-62

737

0

0

0

Loss on induced conversion of debt and debt extinguishment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-77,624

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bargain purchase gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on derivative fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

214,995

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Other income, net

-691

-944

-186

-739

879

841

1,001

944

563

447

138

6,737

6,746

6,697

6,707

-262

-9,314

-10,291

-13,169

-16,320

-11,575

-11,251

0

0

0

-

-

0

-

-56

0

0

0

-

0

-

-

-

-

Total other expense, net

-129,973

-146,835

-158,920

-128,036

-123,618

-121,043

-121,101

-122,075

-117,022

-119,349

-119,154

-100,410

-94,013

-80,918

-100,690

-108,871

-185,325

-188,084

-182,020

-150,562

-74,658

-261,196

-315,042

-328,507

-311,706

-107,272

-12,622

-12,890

-14,498

-14,092

-13,065

-12,067

-10,546

-7,307

0

0

0

-

-

Loss before benefit for income taxes

-18,058

-20,224

-4,514

39,931

29,796

-83,132

-188,321

-277,226

-468,399

-458,811

-564,792

-541,619

-318,088

-226,814

-79,700

-20,827

-161,921

-132,712

-155,714

-181,949

-79,972

-269,687

-338,278

-342,526

-334,429

-150,126

-71,740

-87,978

-92,127

-92,965

-159,160

-155,103

-143,985

-127,948

-49,555

-25,250

0

0

0

Benefit for income taxes

-610,344

-593,244

-86,397

-57,097

-47,597

-44,752

-62,302

-53,821

-60,188

-108,686

-71,444

-106,372

-107,361

-61,251

-67,402

-17,676

-175,600

-172,244

-139,605

-164,626

-3,066

-6,084

-3,421

-114

-1,345

-1,121

-1,303

-6,080

-5,888

-5,171

-18,973

-14,638

-14,665

-14,683

-529

-339

0

0

0

Net loss

592,292

573,020

81,897

97,044

77,413

-38,380

-126,074

-223,426

-408,211

-350,125

-493,348

-435,247

-210,727

-165,563

-12,298

-3,151

13,679

39,532

-16,109

-17,323

-76,906

-263,603

-334,857

-342,412

-333,084

-149,005

-70,437

-81,898

-86,239

-87,794

-140,187

-140,465

-129,320

-113,265

-49,026

-24,911

0

0

0

Net loss per ordinary share—basic and diluted

-0.07

-

-

-0.03

-0.19

-

-

-0.15

-0.90

-

-

-1.29

-0.56

-

-0.04

-

-0.28

-

-

-

-0.16

-

-

-

-3.07

-

-

-0.29

-0.36

-0.13

-0.47

-0.68

-0.98

1.65

-1.30

-7.78

-5.13

-8.38

-

Weighted average ordinary shares outstanding—basic and diluted

190,072

-

-

185,327

172,789

-

-

165,536

164,549

-

-

162,931

161,972

-

161,038

-

159,904

-

-

-

125,650

-

-

-

67,138,463

-

-

62,872

61,939

61,680

35,972

33,715

24,116

19,813

13,256

1,496

1,493

1,490

-

Net income (loss) per ordinary share—basic

-

-

0.10

-

-

-

0.20

-

-

-

-0.39

-

-

-

-

0.09

-

-

0.02

0.21

-

-

0.03

-0.38

-

-

-0.08

-

-

-

-

-

-

-

-

-

-

-

4.62

Weighted average ordinary shares outstanding—basic

-

-

186,470

-

-

-

167,047

-

-

-

163,447

-

-

-

-

160,468

-

-

159,035

150,771

-

-

78,392

73,384

-

-

64,645

-

-

-

-

-

-

-

-

-

-

-

1,490

Net income (loss) per ordinary share—diluted

-

-

0.09

-

-

-

0.19

-

-

-

-0.39

-

-

-

-

0.09

-

-

0.02

0.20

-

-

0.02

-0.38

-

-

-0.08

-

-

-

-

-

-

-

-

-

-

-

0.56

Weighted average ordinary shares outstanding—diluted

-

-

194,171

-

-

-

172,485

-

-

-

163,447

-

-

-

-

163,920

-

-

166,830

159,797

-

-

85,687

73,384

-

-

64,645

-

-

-

-

-

-

-

-

-

-

-

12,363

OTHER COMPREHENSIVE LOSS, NET OF TAX
Foreign currency translation adjustments

-220

-382

-1,211

-535

-1,776

-826

755

679

2,202

2,067

639

738

273

-302

-43

19

-399

1,712

392

-214

-101

-1,960

-422

1,225

1,771

969

270

-240

-1,474

416

-4,009

-10,469

-7,289

-1,559

0

0

0

-

-

Pension remeasurements

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on long-term investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive loss

-220

-382

-1,214

-538

-1,490

-540

1,080

1,004

2,238

2,103

506

605

140

-435

29,357

19

-399

1,712

-29,008

-214

-101

-1,960

-422

1,225

1,771

969

270

-240

-1,474

416

-4,009

-10,469

-7,289

-1,559

0

0

0

-

-

Comprehensive loss

592,072

572,638

80,683

96,506

75,923

-38,920

-124,994

-222,422

-405,973

-348,022

-492,842

-434,642

-210,587

-165,998

17,059

-3,132

13,280

41,244

-45,117

-17,537

-77,007

-265,563

-335,279

-341,187

-331,313

-148,036

-70,167

-82,138

-87,713

-87,378

-144,196

-150,934

-136,609

-114,824

0

0

0

-

-